Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 4Recruiting 3Completed 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 4Nasopharyngeal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Carcinoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Lymphoma, Follicular 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Paclitaxel 2Carboplatin 2trametinib 1tislelizumab 1pembrolizumab 1dabrafenib 1camrelizumab 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Cetuximab 1Capecitabine 1Adjuvants, Pharmaceutic 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Laryngeal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡